Investigators believe that this new anticoagulant, named tecarfarin, will be associated with less therapeutic variability than warfarin because its structure precludes it from being metabolized by ...
Now, a team of UBC Okanagan researchers believe they have found a way to harness the strengths of both technologies in a way that could be life-changing-;and life-saving-;for many. Dr. Hadi ...
Anticoagulants are life-saving medicines that can prevent strokes for patients diagnosed with atrial fibrillation as well as treating patients with venous thromboembolism, but when used incorrectly, ...
Karen L. Hassenplug, Pharm.D.; Jill S. Burkiewicz, Pharm.D., BCPS; Terri L. Jackson, Ph.D., B.S.Pharm.; Laura R. Peppers, Pharm.D., BCPS Identifying baseline ...
A risk score derived and validated by an international team of researchers has identified heart failure and diabetes mellitus as novel risk factors for bleeding in patients with atrial ...